Medical Marijuana Blog Otherside Farms – Medical Marijuana Information and News 
The cannabis industry has seen significant growth of late because of the increasingly loosening rules and regulations around the globe, with respect to the green commodity. As a result, medical marijuana stocks have become a huge deal, and investors are now trying to capture their little piece of what’s sure to become a massive industry.
However, the problem for many investors is determining which medical marijuana stocks will make good investments. In this article with help from a top marijuana dispensary in Phoenix, we are going to give you 5 medical marijuana stocks you should take a look at;
Contents
Canopy Growth Corporation
Canopy Growth Corporation, which was formerly known as Tweed Marijuana Inc., is the largest publicly traded medical marijuana stocks company in the world, and the largest producer of medical cannabis in Canada. The company, through its’ subsidiaries Tweed Inc, Bedrocan and Tweed Farms, is engaged in cultivating and selling medical marijuana. The company offers dry cannabis along with cannabis oil products under various different brands, although the “Tweed” brand is the most popular, thanks to its’ affiliation with the rapper Snoop Dogg.
Today, Canopy is in a great position to lead the way in global exports for medical cannabis with some of the most advanced growing facilities in the industry. In the last couple of months, the company has entered into numerous supply and distribution agreements with the governments of Denmark, Jamaica, and Spain. These business agreements add to their sector leading expansion in Germany, Australia, Chile, and Brazil. As such, investors can expect a strong growth in the company as they keep on growing their business worldwide following the increasing legalization of medical marijuana. That said, it’s important to note that the biggest news for the Canopy Growth company is the eagerly anticipated 2018 launch of recreational marijuana market in Canada. Being the largest supplier of medical marijuana in Canada, Canopy should enjoy a massive growth once this new market is open.
AbbVie Inc
AbbVie is a pharmaceutical company that’s ahead of the pack because it has invested in advanced science so as to find the very best solutions which would enable the treatment of some of the world’s most challenging illnesses. AbbVie discovers, develops, produces and sells pharmaceutical products all over the world. One of their most popular medical marijuana product is the FDA approved Marinol drug which is used for the treatment of nausea in chemotherapy patients. The drug also helps HIV & AIDS patients who have lost appetite. This drug is made of the synthetic form of THC and is then delivered as a capsule. Today, AbbVie is ranked among the top 8 largest biotech companies, and since shifting to the medical cannabis industry, they have reported increasing revenues. The operating income has also been increasing steadily.
GW Pharmaceuticals
GW Pharmaceuticals is a British bio-pharmaceuticals company that’s traded on Nasdaq exchange. It’s one of the largest and longest standing publicly traded cannabis stocks on the planet. The company was actually founded in the year 1998 and produces a wide range of medical products that are derived from the cannabis plant. Currently, its’ leading product is the Epidiolex, which is a pure plant-derived cannabidiol that is used for treating a wide range of diseases including combating the severe drug-resistant epilepsy syndrome. So far, this drug has been a huge success; users have reported experiencing 40% fewer seizures than before, and this confirms the effectiveness of the drug. Another of its’ cannabis-based drugs is the Sativex, which is an internationally approved product for use in the treatment of spasticity which is associated with multiple sclerosis.
Aphria Inc
Aphria Inc., which was formerly known as Black Sparrow Capital Corporation, is a Canadian based company which is engaged in producing, selling and distributing medical marijuana. The company’s business model mainly focuses on online sales. and is licensed under ACMPR; much like the other companies that are on Canadian marijuana stock.
Aphria offers medical marijuana products of various different strains, including, but not limited to; Panache, Kusawa, Tamaracouta, Iroquois, and Churchill. The company also produces low THC products for the patients who are sensitive to cannabis’ psychoactive properties and is engaged in the research, development, and production of cannabis oil.
Aurora Cannabis Corporation
Aurora Cannabis Inc, which was formerly known as Prescient Mining Corp, is a Canada based company, which engages in the production and distribution of medical marijuana. With a market cap of about $1.07 billion, Aurora is a notable player in Canada’s medical marijuana industry. The company mainly deals with the production and sale of the dry medical cannabis, cannabis oil as well as patient counseling services.
Like Canopy Growth, this company is eyeing the international markets. In fact, Aurora recently acquired Pedanios Gmbh (a German medical marijuana market leader). Aurora also intends to acquire another medical marijuana grower in Canada, known as CanniMed Therapeutics. If this deal happens to go through, the combined entity might be valued at over $3 billion. In addition to that, Aurora now owns about 20% of a company which supplies medical marijuana in Australia.
